Amgen Inc BDR (AMGN34)

43.41 -0.50 (-1.14%)
Closed BRL Disclaimer

AMGN34 Financial Summary

Amgen Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 6,594 million compared to USD 6,526 million a year ago. Net income was USD 1,317 million compared to USD 464 million a year ago. Basic earnings per share from continuing operations was USD 2.46 compared to USD 0.81 a year ago. Diluted earnings per share from continuing operations was USD 2.45 compared to USD 0.81 a year ago.For the six months, revenue was USD 12,832 million compared to USD 12,427 million a year ago. Net income was USD 2,793 million compared to USD 2,110 million a year ago. Basic earnings per share from continuing operations was USD 5.16 compared to USD 3.67 a year ago. Diluted earnings per share from continuing operations was USD 5.13 compared to USD 3.65 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
AMGN34
Gross margin TTM 75.75%
Operating margin TTM 37.75%
Net Profit margin TTM 24.92%
Return on Investment TTM 21.92%
Total Revenue
Net Income
Title
Dec 31, 2021
Total Revenue 25,979
Gross Profit
Operating Income
Net Income
Clear All
0Selected
Please try another search
AMGN34
Quick Ratio MRQ 0.99
Current Ratio MRQ 1.53
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 1,509.8%
Total Assets
Total Liabilities
Title
Dec 31, 2021
Total Assets
Total Liabilities
Total Equity
Clear All
0Selected
Please try another search
AMGN34
Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow -
Cash
Net Change in Cash
Title
Dec 31, 2021
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
Clear All
0Selected
Please try another search

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.